Raltegravir Medicines Supply Agreement
Original notice title
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Raltegravir 400 mg (ATC-Code nach WHO: J05AJ01)
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
We couldn't generate the AI analysis for this tender. Please try again later.
Buyer
Name
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Location
Erfurt, DEU
Website
Buyer profile
Identifier
DE256878834
Activity
Health
Lots (1)
LOT-0001
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Raltegravir 400 mg (ATC-Code nach WHO: J05AJ01)
Siehe Kurzbeschreibung
Location
Duration
Category
Award details
Selection criteria
Procurement Details
- Publication date
- 07 kwi 2026
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 238743-2026
Documents (1)
Similar tenders
Romania – Engineering design services for the construction of civil engineering works – Servicii de actualizare expertiză tehnică, DALI și DTAC pentru Corpurile C33 și C35 – Șos. Panduri nr. 90
France – Provision of services to the community – EXPLOITATION DES 7 DECHETERIES GEREES PAR VALCOR ET DES PLATEFORMES DE TRAITEMENT DES DECHETS VEGETAUX
Netherlands – Refuse disposal and treatment – Brengvoorzieningen afvalstromen gemeente Boxtel en Sint-Michielsgestel
Czechia – Architectural, engineering and surveying services – ZŠ v MČ Brno-jih, Bednářova, přístavba - projektová dokumentace
Poland – Advertising material – Dostawa toreb i pudełek papierowych obrandowanych logotypem Dolnego Śląska zgodnie ze Szczegółowym Opisem Przedmiotu Zamówienia
Poland – Reagents and contrast media – Dostawy sukcesywne środków kontrastowych na okres 24 miesięcy z prawem opcji 12 miesięcy ( łącznie 36 miesięcy)
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications